- VernacularTitle:解读 Lancet Neurology发表的主观认知下降的特征
- Author:
Yu SUN
1
;
Xiaoni WANG
;
Guanqun CHEN
;
Can SHENG
;
Xuanyu LI
;
Qin YANG
;
Taoran LI
;
Wenying DU
;
Xiaoqi WANG
;
Li LIN
;
Yi LIU
;
Feng FENG
;
Xiaochen HU
;
Ying HAN
Author Information
- From: Chinese Journal of Neurology 2020;53(5):396-400
- CountryChina
- Language:Chinese
- Abstract: Alzheimer′s disease (AD) is an incurable disease in the field of major chronic diseases. Subjective cognitive decline (SCD) is a clinical risk factor for AD. The standardized screening and intervention in individuals with SCD are of great importance in early prevention and treatment of AD. According to the clinical criteria proposed by The characterisation of subjective cognitive decline, which was published online in Lancet Neurology, the article summarized the definition of SCD, the latest perspective of clinical standards in SCD, and the results of AD preclinical SCD research. The purpose of this work was to provide concrete guidance and recommendations for making clinical decisions in diagnosis and scientific research on SCD.

